Data Published in The Lancet Shows Positive Results at Primary Endpoint in the Treatment of Resistant Hypertension with MobiusHD Device
Publication Follows Positive Interim Results in US and EU Patients Presented at the European Society of Cardiology Conference.
- 04.09.2017, 11:49
- Kategoria: Zdrowie i styl życia
- Źródło: GlobeNewswire